SCHEMBL25708331

SCHEMBL25708331

Cn1c2cc3ccccc3cc2n2c3ccccc3nc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.47
ALDH1A1 P00352 4/20 0.46
KDM4E B2RXH2 4/20 0.46
LMNA P02545 2/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
HPGD P15428 2/20 0.42
TERT O14746 1/20 0.41
PDE2A O00408 1/20 0.41
PDE3B Q13370 1/20 0.41
PDE3A Q14432 1/20 0.41
HSD17B10 Q99714 2/20 0.40
TP53 P04637 1/20 0.40
CYP3A4 P08684 1/20 0.40
MAPK1 P28482 1/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
NPSR1 Q6W5P4 1/20 0.39
EGFR P00533 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25708352 0.88 KDM4E (0.56) ATMALDH1A1KDM4ELMNASMN1; SMN2
SCHEMBL25693507 0.87 ATM (0.45) ATMALDH1A1KDM4ELMNASMN1; SMN2
SCHEMBL12799837 0.85 ATM (0.53) ATMALDH1A1KDM4ELMNASMN1; SMN2
SCHEMBL18083287 0.85 SMN1; SMN2 (0.55) ATMALDH1A1KDM4ELMNASMN1; SMN2
SCHEMBL25708282 0.83 KDM4E (0.54) ATMALDH1A1KDM4ELMNASMN1; SMN2
SCHEMBL20041551 0.82 MEN1 (0.46) ATMALDH1A1KDM4ELMNASMN1; SMN2
SCHEMBL16920049 0.82 KMT2A (0.47) ATMSMN1; SMN2MEN1KMT2AHPGD
SCHEMBL22380119 0.82 GPR3 (0.46) ATMALDH1A1KDM4ELMNASMN1; SMN2
SCHEMBL22380117 0.82 GPR3 (0.46) ATMALDH1A1KDM4ELMNASMN1; SMN2
SCHEMBL20041525 0.80 MEN1 (0.44) ATMALDH1A1KDM4ELMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230209993-A1 LIGHT-EMITTING DEVICE INCLUDING HETEROCYCLIC COMPOUND, ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE, AND THE HETEROCYCLIC COMPOUND SAMSUNG DISPLAY CO., LTD. (KR) 2023-06-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230209993-A1 LIGHT-EMITTING DEVICE INCLUDING HETEROCYCLIC COMPOUND, ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE, AND THE HETEROCYCLIC COMPOUND CRY1, LAGE3, NQO1 ATM 4454/4885ALDH1A1 17/4885KDM4E 2980/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.